U.S.-designed and manufactured AEON⢠surgical stapling systems to support minimally invasive care for veterans, service members and their families

ALEXANDRIA, Va., Nov. 2, 2026 /PRNewswire/ -- MellingMedical today announced a strategic relationship with Lexington Medical, a U.S. medical device manufacturer focused exclusively on surgical stapling technology. Through the collaboration, MellingMedical will leverage its federal healthcare contracting expertise and status as an SBA-verified Service-Disabled Veteran-Owned Small Business (SDVOSB) to expand access to Lexington Medical's AEON⢠surgical stapling systems for providers caring for veterans, active-duty service members and their families.

"Lexington Medical brings a rare combination of focused engineering, clinical innovation and American manufacturing to surgical stapling," said Chris Melling, founder and CEO of MellingMedical. "Its AEON platform gives surgeons versatile options for tissue management in minimally invasive procedures. We look forward to helping federal healthcare providers evaluate and access this technology."

EXPANDING FEDERAL ACCESS

The collaboration is intended to streamline federal customers' access to Lexington Medical's surgical stapling portfolio through MellingMedical's established contracting channels. Designed and manufactured in Bedford, Massachusetts, Lexington Medical's products pair domestic manufacturing with a specialized approach to surgical instrument development.

PURPOSE-BUILT SURGICAL STAPLING TECHNOLOGY

Lexington Medical's AEON platform includes the AEON+⢠manual stapler and AEON⢠Powered Stapling System, both supported by a broad range of specialized reload configurations. The reload portfolio includes proprietary Short Tip options designed for access in confined anatomy, along with choices suited to different tissue types and surgical applications. AEON Powered incorporates intelligent firing technology that adjusts firing speed in response to tissue feedback, while AEON+ offers smooth firing and articulation. The systems are designed to support superior staple formation in thoracic, bariatric, colorectal, hepatopancreatobiliary and general surgical procedures. With millions of units shipped globally and backed by superior head-to-head clinical data, the singular focus on stapling and continuous innovation offers a superior surgical stapling option.

"Our mission is to advance surgical stapling through focused engineering and continuous innovation informed by surgeons," said Leon Amariglio, founder and CEO of Lexington Medical. "We design and manufacture AEON in the United States, with both powered and manual options and a specialized reload portfolio built for the demands of minimally invasive surgery. Working with MellingMedical creates an important pathway to bring these capabilities to surgeons serving veterans and military families."

UNDERSTANDING THE MARKETPLACE

The federal healthcare system represents a significant opportunity to broaden access to innovative medical technologies. As procurement processes and care delivery needs evolve, MellingMedical's federal contracting infrastructure and experience can help Lexington Medical navigate purchasing pathways and engage providers across the Veterans Health Administration, Department of Defense and other federal healthcare settings.

A COMMITMENT TO SERVICE

In conclusion, Chris Melling said, "As federal healthcare systems modernize and cut the red tape that has often slowed down procurement, we have an unprecedented opportunity to elevate the standard of care. By aligning with forward-thinking innovators like Lexington Medical, we are leaning into this new momentum to ensure that state-of-the-art surgical tools reach our clinicians fasterâultimately delivering the exceptional, high-value outcomes our veterans have earned." 

About MellingMedical

MellingMedical, an SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), holds a Medical Equipment and Surgical Federal Supply Schedule (Med/Surg), as well as a Pharmaceutical Schedule and ECAT capabilities, providing innovative and cost-effective healthcare solutions to all 172 VA Medical Centers and 1,138 VA Outpatient Clinics, all seven (7) VA CMOPs, 95 DoD Medical Facilities and Health and Human Services (HHS), including Indian Health Services (IHS) and the Center for Disease Control (CDC). To learn more, visit MellingMedical.com.

About Lexington Medical

Founded in 2013 and headquartered in Bedford, Massachusetts, Lexington Medical, Inc is a U.S. medical device company dedicated exclusively to surgical stapling. Its AEON⢠platform includes manual and powered endoscopic staplers and a broad portfolio of specialized reloads designed to support precision, access and consistent staple formation across a range of minimally invasive procedures. Lexington Medical combines product development, manufacturing and quality control in a vertically integrated U.S. operation, enabling rapid innovation informed by surgeon feedback. AEON staplers have been used in more than 100,000 procedures globally. To learn more, visit lexington-med.com.

SOURCE MellingMedical

Share this article

Eight service lines reflect the firm's investment in a comprehensive suite of advisory capabilities to better serve clients

ST. LOUIS, Nov. 2, 2026 /PRNewswire/ -- Anders announced a formal structure for its advisory practice, with eight service lines organized into two groups: Integrated Operations and Strategy & Transformation. Anders' advisory practice operates alongside the firm's tax and audit practices.

The new structure follows several years of investment in Anders' advisory capabilities through strategic acquisitions, experienced hires and the introduction of new services. Since the firm's 2022 merger with Summit CPA Group, its Virtual CFO practice has nearly doubled. More recently, Anders added Human Capital, Operations Transformation and Transaction Advisory, further broadening the services available to clients.

The structure reflects the breadth of Anders' advisory capabilities, with services spanning ongoing operational support and specialized expertise to address business challenges.

Integrated Operations: Ongoing operational services anchored in finance and technology.

- Technology Managed Services: Outsourced and co-managed IT services that combine day-to-day technology management, cybersecurity, and strategic guidance to help businesses operate efficiently, reduce risk, and maximize their technology investments.

- Virtual CFO: Flexible, subscription-based financial leadership for growing businesses that need CFO-level expertise without hiring a full-time CFO, helping them improve financial visibility, make informed decisions, and plan for growth.

Strategy & Transformation: Deep expertise in finance, people, technology and operations.

- AI & Technology: AI strategy and adoption, technology implementation, process automation, and workflow optimization to reduce manual work, improve productivity, and unlock greater value from technology investments.

- Finance Transformation: Improving financial processes, technology, reporting, and organizational structures to create more effective, scalable finance functions that deliver timely insights and stronger financial controls.

- Human Capital: End-to-end HR strategy and expertise spanning HR operations, talent acquisition and management, employee experience, and workforce strategies aligned with business goals.

- Operations Transformation: Identifying and addressing the root causes of operational challenges through practical improvements that increase efficiency, profitability, and overall business performance.

- Strategic Planning: Strategic assessment, planning, and leadership alignment, supported by actionable roadmaps and accountability frameworks that turn organizational priorities into measurable results.

- Transaction Advisory: Guidance throughout the transaction lifecycle, including financial due diligence, deal structuring, negotiations, and post-close integration planning to manage risk and maximize transaction value.

"We've been intentional about growing our advisory practice because we want to help clients beyond their tax and accounting needs," said Robert Minkler Jr., Anders CEO. "Our clients come to us with questions about all aspects of their businesses. We've invested in the people and capabilities to help them find answers and make better decisions."

"We've spent the past several years expanding our advisory capabilities to build on the tax and audit expertise that has long been a foundation of Anders," said David Hartley, partner-in-charge of advisory at Anders. "When a client comes to us with a challenge involving their finances, technology, people or operations, we can bring together specialists from across the firm to understand the bigger picture and help them move forward."

About Anders

For more than 60 years, Anders has delivered full-service accounting, tax, audit and advisory services to growth-oriented companies, organizations and individuals. Ranked #76 on Accounting Today's List of Top Accounting Firms and a top-four firm headquartered in the Midwest, Anders is a member firm of LEA Global (LEA), one of the largest international associations of independent accounting firms. For more information on Anders, visit anderscpa.com.

Media Contact

Krista Westfall, Brand Marketing Senior Manager | [email protected]

SOURCE Anders

Share this article

- Poster presentation to highlight preclinical efficacy of ATNM-400 across therapy-resistant breast cancer subtypes

- ATNM-400 is a first-in-class targeted alpha therapy directed against HER3, a driver of tumor biology and treatment resistance in multiple solid tumors

- Breast cancer findings reinforce ATNM-400's pan-tumor potential, building on previously reported preclinical results in non-small cell lung, colorectal and ovarian cancers

NEW YORK, Nov. 2, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in differentiated targeted radiotherapies with the potential to transform cancer treatment, today announced that an abstract highlighting preclinical efficacy of ATNM-400 across therapy-resistant breast cancer subtypes has been accepted for poster presentation at the 2026 San Antonio Breast Cancer Symposium (SABCS), taking place December 8â11, 2026, in San Antonio, Texas.

The presentation will feature ATNM-400, the Company's investigational, first-in-class Actinium-225 (²²âµAc) antibody radioconjugate targeting HER3, an antigen implicated in tumor survival and treatment resistance. ATNM-400 combines the targeting specificity of a monoclonal antibody with potent alpha-particle radiation to deliver a tumor-directed cytotoxic payload.

The breast cancer findings build on previously reported preclinical results demonstrating antitumor activity in non-small cell lung cancer (NSCLC) models across EGFR, KRAS and ALK alterations, enhanced responses with standard-of-care therapies in colorectal cancer (CRC) models, and durable activity in ovarian cancer models, including treatment-resistant disease. Together, these findings reinforce ATNM-400's pan-tumor potential and support further evaluation as a standalone therapy and in combination with established treatments across multiple solid tumor indications, complementing its ongoing clinical development in prostate cancer.

"We are excited to showcase ATNM-400's activity in therapy-resistant breast cancer models at SABCS," said Sandesh Seth, Actinium's Chairman and CEO. "Building on our previously reported NSCLC, colorectal and ovarian cancer results, these findings strengthen our vision for developing ATNM-400 as a pan-cancer radiotherapy. HER3 is implicated in resistance to standard-of-care therapies across several solid tumors and treatment settings, which implies  ATNM-400's potential extends well beyond a single oncology setting. Together with our ongoing first-in-human prostate cancer program, this growing body of evidence supports our strategy to pursue ATNM-400's broad potential and address treatment-resistant disease across large patient populations." 

ATNM-400 SABCS 2026 Presentation Details

Abstract Title: ATNM-400 a first-in-class targeted alpha therapy targeting a driver of tumor biology and treatment resistance demonstrates efficacy across therapy-resistant breast cancer subtypes

Abstract Number: 1626

Presentation Number: P2-12-17

Presentation Type: Poster presentation

Presentation Date & Time: Wednesday, December 9, 2026, 5:00â6:30 p.m. CST

Location: Exhibit Hall

About ATNM-400 and HER3

ATNM-400 is an investigational antibody radioconjugate that pairs the HER3-targeting monoclonal antibody barecetamab with the alpha-emitting isotope Actinium-225. Its antibody-based design combines antigen-specific targeting with the potential for sustained tumor localization, supporting prolonged delivery of high-energy alpha radiation. Tumor uptake and retention observed through Day 7 with the â¸â¹Zr-labeled imaging counterpart support this development rationale alongside the approximately 10-day half-life of ²²âµAc. The theranostic approach enables noninvasive visualization of antibody distribution to inform therapeutic development.

ATNM-400 is differentiated from PSMA-targeted radiotherapies by its focus on HER3, an antigen implicated in tumor survival and treatment resistance. PSMA-directed approaches include Novartis' Pluvicto and a broad pipeline of investigational therapies, including Telix Pharmaceuticals' TLX591-Tx, Clarity Pharmaceuticals' â¶â·Cu-SAR-bisPSMA, Convergent Therapeutics' CONV01-α, AstraZeneca's AZD2265 (formerly FPI-2265), Curium's lutetium-177 zadavotide guraxetan (¹â·â·Lu-PSMA-I&T), ARTBIO's AB001 and AdvanCell's ADVC001. These programs span small-molecule and antibody-based therapies using beta- or alpha-emitting isotopes. ATNM-400 combines HER3 targeting with an Actinium-225 antibody radioconjugate, offering a distinct biological approach with the potential to expand radiotherapy across the broad mCRPC population, including patients with PSMA-low or PSMA-negative disease and those who do not respond to or progress following PSMA-directed treatment. Its HER3-directed mechanism also supports investigation beyond prostate cancer in other HER3-expressing solid tumors.

HER3, also known as ERBB3, is a member of the epidermal growth factor receptor family involved in signaling pathways that support tumor growth, survival and resistance to treatment. HER3-directed antibody-drug conjugates in clinical development include BioNTech and MediLink's BNT326/YL202, Bristol Myers Squibb and SystImmune's EGFR Ã HER3 bispecific ADC izalontamab brengitecan (iza-bren), and Daiichi Sankyo and Merck's patritumab deruxtecan (HER3-DXd). These programs underscore the clinical development interest in HER3 as an oncology target. ATNM-400 applies a distinct payload strategy, using alpha radiation in place of a conventional cytotoxic drug. Its preclinical activity in prostate, non-small cell lung and breast cancer models supports investigation as a potential pan-cancer radiotherapy, as a monotherapy and in rational combinations.

About Actinium Pharmaceuticals, Inc.

Actinium is a pioneer in targeted radiotherapies designed to improve outcomes for patients with cancer. The company employs a biology-driven approach to develop differentiated radiopharmaceuticals for solid tumors and hematologic malignancies. Its mission is to transform cancer treatment through innovative radioconjugates that maximize therapeutic efficacy while minimizing toxicity to healthy tissue by combining expertise in tumor biology, translational medicine, and radiochemistry. Since inception, Actinium has focused on developing innovative radiotherapies. Its pipeline reflects this strategy across three areas: (1) solid tumor therapeutics including ATNM-400 and Actimab-A with pan-tumor potential; (2) Actimab-A as a therapeutic backbone for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in collaboration with the National Cancer Institute (NCI); and (3) targeted conditioning agents including Iomab-B for bone marrow transplant and Iomab-ACT for cell and gene therapy conditioning. ATNM-400 targets HER3, an antigen distinct from PSMA, and is in a first-in-human Phase 1 study in metastatic castration-resistant prostate cancer (mCRPC), with preclinical activity across mCRPC, NSCLC, breast, colorectal and ovarian cancers. Actimab-A has shown improved survival in relapsed/refractory AML with CLAG-M and is advancing toward a Phase 2/3 trial, with additional development ongoing through a CRADA with the NCI. Actinium is also advancing preclinical solid tumor programs and holds ~250 patents and patent applications, including intellectual property related to cyclotron-based production of Ac-225. For more information, please visit www.actiniumpharma.com.

Forward-Looking Statements

This press release may contain projections or other "forward-looking statements" within the meaning of the "safe-harbor" provisions of the private securities litigation reform act of 1995 regarding future events or the future financial performance of the Company which the Company undertakes no obligation to update. These statements are based on management's current expectations and are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with preliminary study results varying from final results, estimates of potential markets for drugs under development, clinical trials, actions by the FDA and other governmental agencies, regulatory clearances, responses to regulatory matters, the market demand for and acceptance of Actinium's products and services, performance of clinical research organizations and other risks detailed from time to time in Actinium's filings with the Securities and Exchange Commission (the "SEC"), including without limitation its most recent annual report on form 10-K, subsequent quarterly reports on Forms 10-Q and Forms 8-K, each as amended and supplemented from time to time.

Investor Contact

Peter (PJ) Kelleher

LifeSci Advisors

[email protected]

(617) 430-7579

SOURCE Actinium Pharmaceuticals, Inc.

Share this article

Verband Bildungsmedien e. V.: Iris Kalvelage ist neue stellvertretende Vorsitzende

Christian Fuhrhop neu im Vorstand

Frankfurt am Main (ots)

Iris Kalvelage (Westermann) ist neue stellvertretende Vorsitzende des Verband Bildungsmedien e. V.

Neu in den Vorstand kooptiert wurde zum 28. Oktober 2026 Christian Fuhrhop. Er folgt als Vertreter des Cornelsen Verlags auf Martina Fiddrich, die ihr Vorstandsmandat niedergelegt hat.

Dem Vorstand unter Vorsitz von Maximilian Schulyok (Ernst Klett Verlag GmbH) gehören außerdem Schatzmeisterin Michaela Hueber (Hueber Verlag GmbH & Co. KG), Dr. Jacob Kloepfer (Verlag Europa-Lehrmittel Nourney, Vollmer GmbH & Co. KG) und Hendrik Langner (phase-6 GmbH) an.

Der Verband Bildungsmedien ist der führende Zusammenschluss professioneller Bildungsmedienanbieter in Deutschland.

Pressekontakt:

Verband Bildungsmedien e. V.

Presse- und Öffentlichkeitsarbeit

Dr. Dagny Ladé

Kurfürstenstraße 49

60486 Frankfurt am Main

Tel.: 069 9866976 - 14

https://bildungsmedien.de

Original-Content von: Verband Bildungsmedien e.V., übermittelt durch news aktuell

"Nothing Serious": Die ARD Hörspieltage 2026 in Karlsruhe

Karlsruhe (ots)

5. - 8. November 2026 im ZKM, der HfG und erstmals im Kunstmuseum / mit "Die Nacht des Hörspiels", sechs Hörspielproduktionen, drei Live-Hörspielen und vielen Gästen

Auf dem Programm der 23. Ausgabe der ARD Hörspieltage stehen unter anderem zwei Live-Hörspiele wie die Premiere von "Am Meer lag München nie", der Podcast "1001 Nacht" als Bühnenshow, eine Hörspiel-Revue, das Kinder-Live-Hörspiel "Prinzessin Rosenblüte", satirische Interventionen von Tommy Neuwirth und Stefan Stuckmann. Außerdem "Die Nacht des Hörspiels" mit Gesprächen über die Herausforderungen für humoristisches Erzählen sowie einer Auswahl der lustigsten Hörspiele aller Zeiten. Zu Gast sind Lars Eidinger, Lilith Stangenberg, Kristine Bilkau, Aurel Mertz und viele mehr. Das Festival findet unter Federführung des SWR statt, die Leitung hat Mareike Maage.

Humor, Lachen und Komik

Der Schwerpunkt des bedeutendsten Hörspielfestivals im deutschsprachigen Raum liegt in diesem Jahr auf dem Thema Humor. Es beleuchtet unter dem Motto "Nothing Serious" Humor, Lachen und das ästhetische Prinzip der Komik und erörtert in Podiumsdiskussionen, Hörspielen und Live-Acts die Frage, was Humor ausmacht und wie er sich im Lauf der Zeit verändert hat. Eröffnet wird das viertägige Festival mit der Diskussion "Worüber lachen wir?" mit Hörspielregisseur Leonhard Koppelmann, Comedian Aurel Mertz und Filmregisseurin Isabel Schneider. Am gleichen Abend wird Schauspieler und DJ Lars Eidinger im Kunstmuseum auflegen.

Vielschichtiges Programm rund ums Hörspiel

Insgesamt werden sechs Hörspielproduktionen der ARD, des Deutschlandfunks, des Österreichischen Rundfunks und des Schweizer Radios präsentiert. Die Lauscherlounge und Autorin Jacqueline Meintzinger inszenieren "Holmes & Watson - Detektive am Rande des Ruhestands" als Live-Hörspiel, der Podcast "1001 Nacht" wird als Bühnenshow aufgeführt, das Live-Hörspiel "Am Meer lag München nie" feiert Premiere, und in der Hörspiel-Revue "Viel um die Ohren" spricht Thomas Böhm über die vielfältigen Herausforderungen der Hörspielkunst, u.a. mit Schauspielerin Lilith Stangenberg, Schriftstellerin Kristine Bilkau und Regisseur Martin Heindel. Das Thema Humor lädt auch zum Mitmachen ein - im Foyer etwa bei den Musikworkshops mit Tommy Neuwirth oder dem "Humororakel". Außerdem wird der Preis für die freie Hörspielszene "max15" verliehen, ebenso der "Kinderhörspielpreis der Stadt Karlsruhe". Am Kinderhörspieltag wird Kirsten Boies Kinder-Live-Hörspiel "Prinzessin Rosenblüte" uraufgeführt. Und die berühmte "Maus" und Nina Heuser präsentieren live zwei Hörspiele.

"Ich liebe Hörspiele, sie erlauben mir, mit den Ohren zu sehen!" (Lilith Stangenberg)

Schauspielerin Lilith Stangenberg: "Ich liebe Hörspiele, sowohl sie aufzunehmen als auch zuzuhören. Sie erlauben mir, mit den Ohren zu sehen! Und erzeugen meine eigenen unverbrauchten Bilder. Dadurch verlangen sie mir etwas ab und entlasten mich zugleich. Stimmen können eine hypnotische Wirkung auf mich haben, prägen sich mir markanter ein als Gesichter. Hörspiele sind auch wie Zeitreisen. Ich höre sie am meisten beim Kochen." Stangenberg, die in Filmen wie "Stammheim", "Tatort - Unter Feinden", "Sterben" und "Wild" spielte, wirkte unter anderem auch in den Hörspielen "Sodom und Gomorrha" und "Liebesgeschichte" mit. Bei den diesjährigen ARD Hörspieltagen ist sie am Freitag (6. November) bei der Hörspiel-Revue "Viel um die Ohren" als Gesprächspartnerin für das Hörspiel "Frank: Sonette" anzutreffen, in dem sie ebenfalls mitwirkt.

"Die Nacht des Hörspiels" unter dem Motto "Hörspiel macht Spaß!"

Höhepunkt des Festivals ist "Die Nacht des Hörspiels" mit Talk und Musik, in der auch der "Kinderhörspielpreis der Stadt Karlsruhe" vergeben wird. Moderator Thomas Böhm wird mit seinen Gästen über Sprache und Dialekte als Material für Sketche sprechen und beleuchten, was humoristisches Erzählen so schwierig macht. Auf dem Podium werden Kulturwissenschaftlerin Mithu Sanyal, die Comedy-Autor:innen Stefan Stuckmann und Mariella Tripke und Schauspielerin Cathlen Gawlich sitzen. Außerdem werden Ausschnitte aus den lustigsten Hörspielen aller Zeiten zu hören sein. Durch den Abend führt die Beatboxer-Band "The Razzzones" mit ihren Stimmen, Mundgeräuschen und Mikrofonen.

Kostenfreie Tickets

Aufgrund der großen Nachfrage für die Veranstaltungen des Kinderhörspieltags müssen Besucher:innen in diesem Jahr kostenfreie Tickets für die Live-Hörspiele, die interaktiven Hörspiele, Lesungen und Podcast-Shows am Sonntag erwerben. Diese können ab Samstag, 7. November, 12 Uhr über den SWR Ticketservice oder am Sonntag, 8. November, über die im ZKM ausgehängten QR-Codes reserviert werden. Alle anderen Programmpunkte sind wie in den Jahren zuvor frei zugänglich.

Rechtefreie Pressefotos zum kostenlosen Download: www.ARD-Foto.de

Ausführliche Informationen zum Programm der ARD Hörspieltage 2026 unter: www.hoerspieltage.ARD.de

Pressekontakt:

Pressekontakt SWR: Claudia Gabler, Tel. 07221 929 23273, claudia.gabler@swr.de

Interviewanfragen und Pressematerial: Gitta Deutz, Tel: 0172 20 79 810, pr@presseagentur-deutz.de

Original-Content von: ARD Presse, übermittelt durch news aktuell

AUMA e.V. - Verband der deutschen Messewirtschaft

Von Mensch zu Mensch - AUMA veröffentlicht Studie zu Bedürfnissen von Messebesuchern

Berlin (ots)

- Erste Umfrage dieser Art mit mehr als 1.800 Befragten

- Urteil: Messen sind innovativ und professionell organisiert, Orientierung jedoch ausbaufähig

- Entscheidung für Besuch fällt immer kurzfristiger

Rund 13 Millionen Menschen besuchen die mehr als 300 Messen pro Jahr in Deutschland. Was für das Fachpublikum wie Privatbesucher in Zeiten schnell fortschreitender Digitalisierung den echten Messebesuch lohnend macht, ist erstmals Inhalt einer Studie des Verbands der deutschen Messewirtschaft AUMA. Das Gewinnen von Besuchern am Messestand taucht zunehmend als Herausforderung in den jährlichen Aussteller- und Veranstalter-Befragungen des AUMA auf. Die Studie "Was Besucher heute von Messen erwarten: Bedürfnisse zwischen Zufall und Struktur" ist nun verfügbar.

Das Gesamturteil der 1.855 Befragten: Messen werden als relevant und qualitativ hochwertig wahrgenommen. Für mehr als 71 Prozent gelten Messen als verlässliche Informationsquelle. Vor allem bieten Messen, was sich digital nur schwer ersetzen lässt: Menschen begegnen Menschen. Zufallsbegegnungen sind hierbei am bedeutendsten. Damit bestätigt sich die besondere Funktion von Messen als Orte, an denen Kontakte nicht nur geplant stattfinden, sondern auch spontan entstehen.

Messen ermöglichen Erfahrungen, die online nicht möglich sind: Fast 82 Prozent der Befragten stimmen der Aussage zu, auf Messen Dinge erleben zu können, die im digitalen Raum nicht in gleicher Weise möglich sind - der höchste Zustimmungswert der Befragung. Produkte werden auf Messen greifbar, aus Informationen entstehen Erlebnisse. 72 Prozent geben an, dass Innovationen auf Messen nachvollziehbar präsentiert werden. Messen werden damit nicht nur als Schaufenster neuer Entwicklungen wahrgenommen, sondern auch als Orte von Einordnung und Vermittlung.

Im Kern erleben Besucherinnen und Besucher Messen als abwechslungsreich, innovativ und professionell organisiert. 73 Prozent beschreiben die Atmosphäre als offen und locker. Der hohe Wert stützt das Bild eines Veranstaltungsformats, das Information mit einer vergleichsweisen offenen sozialen Situation verbindet. Darüber hinaus bildet die gute Organisation das größte Qualitätsmerkmal und wird über alle Besuchergruppen hinweg ähnlich positiv bewertet.

Überraschend: Digitale Angebote stehen nicht im Mittelpunkt der Besucherbedürfnisse. Messen sollen vor allem einen gebündelten Überblick über den Markt bieten, Produkte unmittelbar erlebbar sein. Die Übersichtlichkeit des Angebots und gute Orientierung auf dem Messegelände gehören zu den wichtigsten Erwartungen. Besucher wollen eine bessere Führung über die Messe.

Eine wesentliche Erkenntnis: Die Entscheidung für den Messebesuch fällt oft kurzfristig. Fast 40 Prozent entscheiden sich ein bis vier Wochen vor Veranstaltungsbeginn, knapp 23 Prozent sind noch spontaner. Für Veranstalter wie Aussteller eine Zeit zwischen Hoffen und Bangen.

Die Befragung zeigt, dass am häufigsten eine persönliche Empfehlung das Interesse für einen Messebesuch weckt. Privatbesucher achten besonders auf Eintrittspreise und Reiseaufwand, erst dann auf die Relevanz der Aussteller. Etwa 40 Prozent aller Messen in Deutschland sind Messen für Endverbraucher, 60 Prozent sind Fachbesuchermessen. Für das Fachpublikum entscheidet vor allem die Qualität des Angebots: Für rund 60 Prozent ist die Relevanz der Aussteller das wichtigste Kriterium, Anreise und Eintrittspreis folgen dahinter.

Befragt wurden deutschsprachige Messebesucherinnen und -besucher zwischen 18 und 64 Jahren, die zwischen April 2025 und April 2026 mindestens eine Messe in Deutschland besucht haben.

Der AUMA ist der Ausstellungs- und Messe-Ausschuss der Deutschen Wirtschaft e.V., der Dachverband der deutschen Messewirtschaft. International wie national vertritt er die Interessen aller großen und mittleren Messegesellschaften Deutschlands, internationaler Veranstalter in Deutschland sowie der Verbände, welche Aussteller, Service-Unternehmen, kleine Messeveranstalter, Besucherinnen und Besucher vertreten.

Gleich 70 Messeplätze zwischen Nordsee und Bodensee machen das Messeland weltweit einmalig. Zwei Drittel aller Leitmessen der Weltwirtschaft finden hierzulande statt. 66 Prozent der Aussteller und 33 Prozent der Fachbesucher aller Leitmessen kommen im Schnitt aus dem Ausland. Internationale, nationale und regionale Messen in Deutschland ziehen in Spitzenzeiten bis 230.000 ausstellende Unternehmen und 13 Millionen Besucherinnen und Besucher an.

Durch Messen in Deutschland werden wenigstens 280.000 Jobs gesichert. Die Messewirtschaft in Deutschland trägt Jahr für Jahr mit gut 30 Milliarden Euro an wirtschaftlichen Effekten zum Wohlstand des Landes bei. Bund, Länder und Gemeinden allein nehmen 5,4 Milliarden Euro an Steuern durch Messen in Deutschland ein.

Die Studie "Was Besucher heute von Messen erwarten: Bedürfnisse zwischen Zufall und Struktur" finden Sie hier: https://ots.de/YZ6EY2

- Bildmaterial finden Sie hier: https://ots.de/321cTd

- Hier finden Sie den AUMA-Veranstalter-Ausblick 2026/2027: https://ots.de/aHTXAK

- Hier finden Sie den AUMA-Aussteller-Ausblick 2026/2027: https://ots.de/09cCPb

Pressekontakt:

Steffen Schulze,

Leiter Kommunikation und Marketing im AUMA,

E-Mail: s.schulze@auma.de,

Mobil: 0175-2204600

Original-Content von: AUMA e.V. - Verband der deutschen Messewirtschaft, übermittelt durch news aktuell

Tourismusgenossenschaft Klausen, Barbian, Feldthurns und Villanders

4 Orte und 100 Wintermomente: Der Winter in der Südtiroler Ferienregion Klausen überrascht

Klausen (ots)

Beim Winterurlaub denkt man nicht unbedingt zuerst an das Eisacktal. Dabei erfüllt die Ferienregion rund um Klausen, Barbian, Feldthurns und Villanders nahezu alle Winterwünsche: vom Skifahren mit Dolomitenpanorama über Rodelspaß für die ganze Familie, Winterwanderungen, Skitouren und Langlaufen durch verschneite Landschaften bis hin zu einem Advent wie aus dem Märchenbuch.

Der Eisacktaler Winterstart ist romantisch

Wenn Lichter die mittelalterlichen Gassen erhellen, der Duft von Glühwein durch die Altstadt zieht und traditionelle Handwerkskunst zum Entdecken einlädt, beginnt in Klausen eine besondere Zeit. Der Klausner Gassladvent verwandelt die historische Stadt an den Wochenenden und ausgewählten Tagen zwischen 27. November und 23. Dezember 2026 in einen stimmungsvollen Weihnachtsmarkt. Zwischen alten Bürgerhäusern und verwinkelten Gassen warten handgefertigte Kostbarkeiten, kunstvolle Krippenfiguren und Südtiroler Spezialitäten

Der Eisacktaler Winter bewegt

Auf die Bretter, fertig, los! Die Ferienregion ist ein idealer Ausgangspunkt für abwechslungsreiche Tage im Schnee. Die Wintersafari eröffnet Möglichkeiten, verschiedene Skigebiete der Dolomiten und Umgebung zu entdecken. Dazu zählen Gröden, die Seiser Alm, die Plose, Gitschberg Jochtal und das Rittner Horn. Skifahrer finden dort Pisten für unterschiedliche Ansprüche und Schwierigkeitsgrade.

Auch Rodelspaß gehört zum Schneeabenteuer dazu. Auf der Villanderer Alm warten familienfreundliche Rodel-Strecken, bei Latzfons bieten die Rodelbahnen im Bereich Lahnwiesen abwechslungsreiche Abfahrten für Groß und Klein.

Wer die Berge aus eigener Kraft erobern möchte, entdeckt bei Skitouren die verschneiten Hänge und Gipfel der Umgebung. Schneeschuhwanderungen und geführte Winterwanderungen ergänzen das Angebot.

Der Eisacktaler Winter kann auch gemütlich

Nach einem aktiven Tag im Schnee locken die vier Orte mit ihrem ganz eigenen Charme. Klausen begeistert mit mittelalterlichen Fassaden, kleinen Geschäften, Kunsthandwerk und gemütlichen Cafés. Barbian bezaubert mit seinem markanten schiefen Kirchturm und den traditionellen Weilern. In Feldthurns, auch das Kastaniendorf genannt, warten unberührte Schneefelder und der einzigartige Blick auf die Geislerspitzen, während Villanders mit historischen Höfen und seinem ursprünglichen Dorfcharakter zum Entdecken einlädt.

Und zu guter Letzt: Der Eisacktaler Winter liebt Genuss

Was wäre ein Wintertag ohne eine genussvolle Einkehr. Knödel, Schlutzkrapfen, herzhafte Südtiroler Gerichte und süße Spezialitäten schmecken nach Stunden an der frischen Luft besonders gut. In Hütten, Gasthäusern und Restaurants kommen regionale Zutaten und traditionelle Rezepte auf den Tisch, begleitet von Südtiroler Weinen und herzlicher Gastfreundschaft. Die Verbindung aus alpiner Küche und mediterranen Einflüssen macht jeden Wintertag auch zu einem kulinarischen Erlebnis. www.klausen.it

Pressekontakt:

Tourismusgenossenschaft Klausen, Barbian, Feldthurns und Villanders

Marktplatz 1

I-39043 Klausen

Tel.: +39 0472 847 424

Mail: info@klausen.it

Web: www.klausen.it

Maria Liebewein

ml@dimaconcept.de

www.urlaubsinspirationen.com

Original-Content von: Tourismusgenossenschaft Klausen, Barbian, Feldthurns und Villanders, übermittelt durch news aktuell

Mena-Watch - Der unabhängige Nahost-Thinktank

Verleihung des Arik-Brauer-Publizistikpreises 2026

Wien (ots)

Ehrung für Sarah Maria Sander und Andrea Schurian.

Am Abend des 5. November wird in Wien der Arik-Brauer-Publizistikpreis 2026 an die Filmemacherin und Journalistin Sarah Maria Sander und die Journalistin Andrea Schurian verliehen.

Filmemacherin und Journalistin Sarah Maria Sander hat insbesondere nach dem Hamas-Massaker am 7. Oktober 2023 in Israel festgestellt, dass viele Medien im deutschen Sprachraum ein Bild des Landes vermitteln, das nicht der Realität entspricht: Oft ist es von Halbwahrheiten, Verzerrungen und Desinformation geprägt. Deshalb ging sie selbst nach Israel, um von dort aus mit ihren Zeitungsberichten, Videobeiträgen und Filmen Einspruch gegen die einseitige Israel-Berichterstattung und israelbezogenen Antisemitismus zu erheben. Die Laudatio hält der Buchautor und Journalist Tobias Huch.

Die Autorin und Journalistin Andrea Schurian leitete nach langjähriger Mitarbeit beim ORF von 2008 bis 2017 das Kulturressort der Tageszeitung Der Standard und war Chefredakteurin des vierteljährlich erscheinenden jüdischen Magazins Nu. Seit 2018 kommentiert sie in der Rubrik »Quergeschrieben« in der Tageszeitung Die Presse aktuelle Fragen des Zeitgeschehens. Immer wieder wendet sie sich in ihren Kolumnen gegen Antisemitismus und Israelhass. Die Laudatio hält die Co-Leiterin des Feuilletons der Presse Almuth Spiegler.

Der Arik-Brauer-Publizistikpreis wird einmal jährlich vom Wiener Nahost-Thinktank Mena-Watch für fundierte Beiträge zur öffentlichen Debatte verliehen, die den Nahen Osten aus einer fairen und realitätsbezogenen Perspektive betrachten. Die Preisträgerinnen und Preisträger werden von einer unabhängigen internationalen Jury bestimmt.

Den Preis erhielten zuvor u. a. die Literaturnobelpreisträgerin Herta Müller, der Historiker und Publizist Michael Wolffsohn, die Journalisten Ester Schapira und Christian Ultsch, die Autorin Mirna Funk, die Terrorismusexpertin Rebecca Schönenbach, der Publizist Arye Sharuz Shalicar und der Psychologe Ahmad Mansour, der Journalist Nikolaus Wildner, der Schriftsteller Karl-Markus Gauß und die Politikerin Karoline Preisler. Eine Auszeichnung für sein Lebenswerk erhielt darüber hinaus der Liedermacher und Lyriker Wolf Biermann.

Die Preisverleihung in kleinerem Rahmen beginnt um 19 Uhr. Sie wird unter dem Link https://youtube.com/live/xeYJmbcLiDM?feature=share live gestreamt. Interessierte Journalisten können per Mail an sabine.pribil@thespis.com oder telefonisch von Montag bis Donnerstag von 9 bis 12 Uhr unter der Nummer 01/710 9999-830 ihre persönliche Teilnahme anmelden.

Pressekontakt:

Mena-Watch – Der unabhängige Nahost-Thinktanl

Florian Markl

Telefon: +436644427750

E-Mail: markl@mena-watch.com

Website: https://www.mena-watch.com

Original-Content von: Mena-Watch - Der unabhängige Nahost-Thinktank, übermittelt durch news aktuell

Choice Hotels International Reports Third Quarter 2026 Results

U.S. Net Rooms Growth Rate Improves for Third Consecutive Quarter

Owned Hotel Sales Advance Asset-Light Strategy

Full-Year 2026 RevPAR Outlook Raised

NORTH BETHESDA, Md., Nov. 2, 2026 /PRNewswire/ -- Choice Hotels International, Inc. ("Choice" or "the Company") (NYSE: CHH), a leading global lodging franchisor with an asset-light model, today reported results for the third quarter ended September 30, 2026.

Highlights include:

- Net income was $58 million, or $1.28 per diluted share, for the third quarter.

- Adjusted EBITDA totaled $193 million and adjusted diluted EPS was $2.33 for the third quarter.

- The U.S. year-over-year net rooms growth rate continued to improve, with U.S. rooms approximately flat compared to September 30, 2025, as third-quarter room exits declined 23% compared to the same period of 2025.

- Global net rooms grew 1.7% compared to September 30, 2025, led by 2.5% growth across the higher-revenue extended stay, midscale, and upscale brands.

- U.S. RevPAR increased 3.8% in the third quarter compared to the same period of 2025, reflecting improvements in both occupancy and rate.

- U.S. franchise agreements awarded increased 24% in the third quarter compared to the same period of 2025, representing 6,900 new rooms for development.

- The U.S. conversion pipeline grew to 25,500 rooms, an increase of 6% from June 30, 2026, and 29% from September 30, 2025, driving sequential growth in the total U.S. pipeline.

- The U.S. average royalty rate expanded 8 basis points to 5.23% in the third quarter compared to the same period of 2025.

- Subsequent to quarter-end, the Company completed the sale of two owned hotels for estimated net cash proceeds of approximately $34 million, while retaining franchise agreements for both properties.

- The Company returned $211 million to shareholders through dividends and share repurchases during the first nine months of 2026.

- The Company raised its full-year U.S. and global RevPAR outlooks, revised its net income guidance, and raised its adjusted EBITDA guidance range.

"Our third-quarter results reflect continued progress against our key priorities: the U.S. net rooms growth rate improved for the third consecutive quarter, U.S. RevPAR growth strengthened, and capital recycling is underway," said Dom Dragisich, President and Chief Executive Officer. "Our focus is on returning to the fundamentals that have driven our success for decades, while continuing to invest in commercial and technology capabilities that help franchisees capture more demand. We expect U.S. net rooms growth to accelerate to approximately 1% by year-end, and stronger demand trends support our increased full-year RevPAR outlook. These improvements position us to deliver more consistent financial performance and stronger long-term free cash flow for shareholders."

Financial Performance

- Net income was $58 million for the third quarter, a 68% decline compared to the same period of 2025. The decline primarily reflected a $100 million gain from the acquisition of a joint venture recognized in the prior-year quarter. Current-year results included a $24 million charge related to the termination of an arrangement involving an option to acquire a European hospitality business operating primarily under a lease-based model and a $6 million non-cash impairment charge related to two owned hotels. These impacts were partially offset by higher franchise and management fees. The prior-year gain and both current-year charges are excluded from adjusted results.

- Adjusted EBITDA increased 1% to $193 million for the third quarter compared to the same period of 2025, primarily driven by higher U.S. royalties, partially offset by lower liquidated damages revenue and higher adjusted SG&A expenses. Excluding liquidated damages revenue of $3.3 million and $9.5 million in the third quarters of 2026 and 2025, respectively, adjusted EBITDA increased 5% compared to the same period of 2025.

- Adjusted diluted EPS increased 11% for the third quarter compared to the same period of 2025, benefiting from higher franchise and management fees and share repurchases.

- Franchise and management fees increased 5% to $204 million for the third quarter compared to the same period of 2025, primarily reflecting higher U.S. royalties driven by RevPAR growth and royalty rate expansion, increased franchisee programs and services revenue, and higher international royalties.

RevPAR

- U.S. RevPAR increased 3.8% in the third quarter compared to the same period of 2025, driven by a 1.0% increase in rate and a 160-basis-point increase in occupancy, with strength in the West South Central and Midwest regions.

- International RevPAR increased 3.7% on a currency-neutral basis in the third quarter compared to the same period of 2025, reflecting growth across all regions, led by strength in the Caribbean and Latin America.

System Size and Development

- Global room openings totaled 6,000 in the third quarter, compared to 12,800 in the same period of 2025, which included a 7,400-room international portfolio conversion.

- U.S. room openings totaled 4,400 in the third quarter, compared to 4,800 in the same period of 2025. For the nine months ended September 30, 2026, U.S. room openings increased 17% compared to the same period of 2025.

- Global extended stay net rooms grew 10.7% compared to September 30, 2025, marking the 13th consecutive quarter of double-digit growth. During the quarter, the Company also opened its 600th extended stay hotel.

- International net rooms grew 7.3% compared to September 30, 2025, led by growth in EMEA, Asia-Pacific, and Canada.

- Global franchise agreements awarded represented 9,000 new rooms for development in the third quarter, compared to 11,800 rooms in the same period of 2025, which included a 4,900-room international portfolio signing. In the U.S., franchise agreements awarded represented 6,900 rooms, compared with 5,500 rooms in the same period of 2025.

- The Company's global pipeline totaled 78,200 rooms as of September 30, 2026, with 96% concentrated in extended stay, midscale, and upscale brands. The pipeline included:

- 71,700 U.S. rooms and 6,500 international rooms.

- 30,300 extended stay rooms, representing 39% of the total pipeline.

- 28,100 conversion rooms and 50,100 new-construction rooms.

Balance Sheet and Liquidity

As of September 30, 2026, the Company had total available liquidity of $928 million, consisting of cash and cash equivalents and available borrowing capacity. The Company's net debt-to-adjusted EBITDA ratio was 3.2x for the trailing twelve months ended September 30, 2026, within its target range of 3.0x to 4.0x. The quarter-end cash balance included borrowings made in advance of the October 1, 2026, acquisition of Harvest Hosts. Following the acquisition, net leverage remained within the Company's target range.

In August 2026, the Company completed a $500 million unsecured term loan financing, reducing the borrowing spread on the refinanced debt by 15 basis points and increasing available capacity under its $1 billion revolving credit facility. The term loan matures in August 2029.

During the nine months ended September 30, 2026, the Company generated $122 million in cash flows from operating activities, compared to $185 million in the prior-year period. The decrease primarily reflected the contract termination payment, higher franchise agreement acquisition costs associated with a 17% increase in U.S. room openings, and higher marketing and reservation system reimbursable expenses, partially offset by deferred tax and working capital timing effects.

Asset Recycling

During the nine months ended September 30, 2026, net capital outlays for hotel development and lending activities declined 56% to $36.3 million, compared to $82.0 million in the prior-year period.2

The Company advanced its return to an asset-light franchising model through sales from its owned hotel portfolio. Subsequent to quarter-end, the Company sold two owned hotels, generating estimated net cash proceeds of approximately $34 million while retaining franchise agreements for both properties. As of November 2, 2026, the Company owned 17 operating hotels, with one additional hotel under construction.

Acquisition

On October 1, 2026, the Company acquired Harvest Hosts, an asset-light RV travel subscription platform with recurring revenue, expanding Choice Hotels' offerings for value-minded travelers into the outdoor travel market. The approximately $130 million transaction was funded with available cash and borrowings under the Company's revolving credit facility.

Shareholder Returns

During the nine months ended September 30, 2026, the Company returned $39 million to shareholders through dividends and $172 million in share repurchases.3

As of September 30, 2026, 1.3 million shares of common stock remained available for repurchase under the Company's current share repurchase authorization.

Outlook

The Company is updating certain aspects of its full-year 2026 outlook. The outlook includes forward-looking non-GAAP measures used by management to assess expected performance. Adjusted metrics exclude the net surplus or deficit from reimbursable activities related to franchised and managed properties, due diligence and transition costs, and other items. The outlook includes Harvest Hosts' operating results from the October 1, 2026, acquisition date and reflects the impact of the Company's two recent hotel dispositions, except as otherwise noted.

The net income guidance range has been lowered from the Company's prior outlook primarily to reflect higher expected marketing and reservation system reimbursable expenses, driven by increased investment in franchisee-facing tools and guest delivery capabilities.

LONDON, Nov. 2, 2026 /PRNewswire/ -- Brightstar Lottery PLC (NYSE: BRSL) ("Brightstar") announced today that it will showcase its extensive portfolio of lottery solutions at the World Lottery Summit ("WLS") 2026, November 9-12, in Sydney, Australia. Brightstar's team of lottery experts will highlight capabilities across game experiences, retail, intelligent operations and insights, and connected play to drive player engagement and position lotteries for long-term growth.

"We are excited to reconnect with global lottery leaders at WLS 2026 for the first time as a pure-play lottery business and share how Brightstar's strategic investments in lottery-focused technology, data-driven insights, and enhanced player experiences are leading the way to 'What's Next' for the lottery industry," said Marco Tasso, Brightstar Executive Vice President and Chief Operating Officer, Global Lottery. "Lotteries around the world are navigating changing player expectations, experiencing digital transformation, and balancing sustainable development. We look forward to showcasing our innovative solutions designed to help lotteries adapt, evolve, and deliver long-term value for players and communities."

WLS attendees who visit Brightstar's booth can explore how Brightstar is helping to modernize lottery's next chapter:

- Games that Connect with Every Kind of Player: Brightstar will showcase its evolving portfolio of omnichannel content and digital engagement offerings that provide players with connected experiences through retail and digital channels. Brightstar will debut its groundbreaking new category for iLottery, eDraw Plusâ¢, that maintains the trusted foundation of traditional draw products while introducing story-driven games, on-demand draws, and immersive experiences designed for today's digital players. . Attendees can also explore Brightstar's portfolio of licensed omnichannel content with iconic brands including Wheel of Fortune, Ghostbustersâ¢, and Rubiksâ¢, as well licensed brands for Instants games including Pan Amâ¢. Brightstar's patented draw games and instant ticket innovations will also be featured in this area of the booth.

- Drive Retail Growth: Brightstar will demonstrate a range of retail products and services designed to simplify and enhance retail experiences for lotteries, retailers, and their players. Visitors can learn how Brightstar utilizes artificial intelligence (AI)-powered tools to support efficient sales and retail team operations. Featured products include a full suite of retail terminals including Retailer Lens, a new device designed with versatility in mind for ticket, barcode, QR code, and mobile content scanning.

- Accelerate Insights: Visitors will discover how Brightstar is leveraging AI, advanced analytics, and automation to help lotteries uncover valuable insights, create more engaging player experiences, and improve efficiency amongst lottery teams for better operation. Featured innovations in this area of the booth include Brightstar's Agentic Reporting Assistant made to simplify interaction with lottery data, and Game Planner, an AI-powered tool created to enhance and facilitate instant-game planning and forecasting.

- Elevate Every Play: Showcased in this area will be Brightstar's latest retail solutions designed to bridge physical and digital channels for lotteries, providing players with a more personalized and convenient experience. Attendees can also discover how Brightstar enhances convenience and engagement through innovations such as mobile-enabled game discovery, self-service claims, and paperless instant ticket concepts.

Brightstar leaders will also participate in WLS 2026 speaking events, including:

- Tuesday, November 10

- Brightstar's Platinum Contributor Session will be presented by Wendy Montgomery, Brightstar Senior Vice President Global Marketing, Insights and Sales Development.

- Wednesday, November 11

- Brightstar will be represented at the Platinum Contributors Panel Session by Marco Tasso, Brightstar Executive Vice President and Chief Operating Officer Global Lottery.

About Brightstar Lottery PLC

Brightstar Lottery PLC (NYSE: BRSL) is a global leader in lottery focused on innovation and forward-thinking strategies, building on our renowned expertise in delivering secure technology and producing reliable, comprehensive solutions for our customers. As a premier pure play global lottery company, our best-in-class lottery operations, retail and digital solutions, and award-winning lottery games enable our customers to achieve their goals, entertain players and distribute meaningful benefits to communities. Brightstar has a well-established local presence and is a trusted partner to governments and regulators around the world, creating value by adhering to the highest standards of service, integrity, and responsibility. Brightstar serves nearly 90 lottery customers and their players on six continents. It is the primary technology provider to 26 of the 46 lottery jurisdictions in the U.S. and eight of the world's 10 largest lotteries with central systems. Brightstar has approximately 6,000 employees. For more information, please visit www.brightstarlottery.com or follow along on LinkedIn.

Cautionary Statement Regarding Forward-Looking Statements

This news release may contain forward-looking statements (including within the meaning of the Private Securities Litigation Reform Act of 1995) concerning Brightstar Lottery PLC and its consolidated subsidiaries (the "Company") and other matters. These statements may discuss goals, intentions, and expectations as to future plans, trends, events, products and services, customer relationships, results of operations, or financial condition, or otherwise, based on current beliefs of the management of the Company as well as assumptions made by, and information currently available to, such management. Forward-looking statements may be accompanied by words such as "aim," "anticipate," "believe," "plan," "could," "would," "should," "shall," "continue," "estimate," "expect," "forecast," "future," "guidance," "intend," "may," "will," "possible," "potential," "predict," "project" or the negative or other variations of them. These forward-looking statements speak only as of the date on which such statements are made and are subject to various risks and uncertainties, many of which are outside the Company's control. Should one or more of these risks or uncertainties materialize, or should any of the underlying assumptions prove incorrect, actual results may differ materially from those predicted in the forward-looking statements and from past results, performance, or achievements. Therefore, you should not place undue reliance on such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include (but are not limited to) macroeconomic, regulatory and political uncertainty, including as a result of new or increased tariffs, trade wars, and other restrictions on trade between or among countries in which the Company operates, and related changes in discretionary consumer spending and behavior, fluctuations in foreign currency exchange rates, and the other factors and risks described in the Company's annual report on Form 20-F for the financial year ended December 31, 2025 and other documents filed or furnished from time to time with the SEC, which are available on the SEC's website at www.sec.gov and on the investor relations section of the Company's website at www.brightstarlottery.com. Except as required under applicable law, the Company does not assume any obligation to update these forward-looking statements. You should carefully consider these factors and other risks and uncertainties that may affect the Company's business. All forward-looking statements contained in this news release are qualified in their entirety by this cautionary statement. All subsequent written or oral forward-looking statements attributable to the Company, or persons acting on its behalf, are expressly qualified in their entirety by this cautionary statement.

Contact:

Mike DeAngelis, Corporate Communications, +1 (401) 392-1000, [email protected]

Matteo Selva, Italian media inquiries, +39 366 6803635

James Hurley, Investor Relations, +1 (401) 392-7190

RUBIK'S TM & © Spin Master Toys UK Limited, used under license. All rights Reserved.

Ghostbusters TM & © 2026 Columbia Pictures Industries, Inc. All Rights Reserved.

Pan Am TM & © 2026 Pan American World Airways, LLC. All Rights Reserved.

©2026 Califon Productions, Inc. All Rights Reserved.

© 2026 Brightstar Lottery PLC

The trademarks and/or service marks used herein are either trademarks or registered trademarks of Brightstar Lottery PLC, its affiliates or its licensors.

SOURCE Brightstar Lottery PLC

Share this article